NCT02446782View on ClinicalTrials.gov

Efficacy and Safety of Prophylactic Use of an Antibiotic for Medical Thoracoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

June 30, 2016

Conditions
Pleural EffusionPleurisyEmpyema
Interventions
DRUG

Cefazolin

Cefazolin 2 gm administered in 100 mL normal saline (after skin sensitivity testing) 15-30 minutes before the start of the procedure. Clindamycin 900 mg to be administered if sensitivity detected to cefazolin.

OTHER

saline

100 mL normal saline 15-30 minutes before the start of the procedure

Trial Locations (1)

160012

PGIMER, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT02446782 - Efficacy and Safety of Prophylactic Use of an Antibiotic for Medical Thoracoscopy | Biotech Hunter | Biotech Hunter